MAB5256
Anti-Neurofilament 200 kDa Antibody, clone NE14
clone NE14, Chemicon®, from mouse
Synonym(s):
Anti-CMT2CC, Anti-NFH
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Recommended Products
biological source
mouse
Quality Level
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
NE14, monoclonal
species reactivity
rat, pig, human
manufacturer/tradename
Chemicon®
technique(s)
immunohistochemistry: suitable
isotype
IgG1
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Gene Information
human ... NEFH(4744)
pig ... Nefh(100156492)
rat ... Nefh(24587)
General description
Neurofilaments are a type of intermediate filament that serve as major elements of the cytoskeleton supporting the axon cytoplasm. They are the most abundant fibrillar components of the axon, being on average 3-10 times more frequent than axonal microtubules. Neurofilaments (10nm in dia.) are built from three intertwined protofibrils which are themselves composed of two tetrameric protofilament complexs of monomeric proteins. The neurofilament triplet proteins (68/70, 160, and 200 kDa) occur in both the central and peripheral nervous system and are usually neuron specific. The 68/70 kDa NF-L protein can self-assemble into a filamentous structure, however the 160 kDa NF-M and 200 kDa NF-H proteins require the presence of the 68/70 kDa NF-L protein to co-assemble. Neuromas, ganglioneuromas, gangliogliomas, ganglioneuroblastomas and neuroblastomas stain positively for neurofilaments. Although typically restricted to neurons, neurofilaments have been detected in paragangliomas and adrenal and extra-adrenal pheochromocytomas. Carcinoids, neuroendocrine carcinomas of the skin, and oat cell carcinomas of the lung also express neurofilaments. For more neurofilament information see Nervous System Cell Type Specific Marker chart online under the CHEMICON Technical Support section.
Specificity
The antibody reacts with neurofilament 200 kD.
Immunogen
Purified neurofilament polypeptides (Debus et al., 1983).
Application
Detect Neurofilament 200 kDa using this Anti-Neurofilament 200 kDa Antibody, clone NE14 validated for use in IH.
Immunohistochemistry: 5-10 μg/mL (See below protocol.)
Optimal working dilutions must be determined by end user.
Immunohistochemistry Protocol for Anti-Neurofilament 200 kD
Ideal specimens are obtained from frozen sections from shock-frozen tissue samples. The frozen sections are dried in the air and then fixed with acetone at -15 to -25°C for 10 min. Excess acetone is allowed to evaporate at 15-25°C. Material fixed in alcohol and embedded in paraffin can also be used, see (Altmannsberger et al., 1982). The antibody appears to react with tissue fixed in formaldehyde for a short time (10 min) (Debus et al., 1983). Other fixation conditions must be first tested by the investigator.
It is advantageous to block unspecific binding sites by overlaying the sections with fetal calf serum for 20-30 min at 15-25°C. Excess of fetal calf serum is removed by decanting before application of the antibody solution. Cytocentrifuge preparations of single cells or cell smears are also fixed in acetone. These preparations should, however, not be dried in the air. Instead, the excess acetone is removed by briefly washing in phosphate-buffered saline (PBS).
Further treatment is then as follows:
Overlay the preparation with 10-20 μL antibody solution and incubate in a humid chamber at 37°C for 1 h.
Dip the slide briefly in PBS and then wash 3 times in PBS for 3 min (use fresh PBS each time)
Wipe the margins of the preparation dry and overlay the preparation with 10-20 μL of an anti-mouse Ig-FITC or anti-mouse Ig-POD antibody and allow to incubate for 1 h at 37°C in a humid chamber.
Wash the slide as described above.
The preparation must not be allowed to dry out during any of the steps.
If using an indirect immunofluorescence technique, the preparation should be overlaid with a suitable embedding medium (e.g. Moviol, Hoechst) and examined under the fluorescence microscope. If a POD-conjugate has been used as the secondary antibody, the preparation should be overlaid with a substrate solution (see below) and incubated at 15-25°C until a clearly visible red-brown color develops. A negative control (e.g. only the secondary antibody) should remain unchanged in color during this incubation period. Subsequently, the substrate is washed off with PBS and the preparation is stained, if desired, with hemalum stain for about 1 min. The hemalum solution is washed off with PBS, the preparation is embedded and examined.
Substrate solutions:
Aminoethyl-carbazole:
Dissolve 2 mg 3-amino-9-ethylcarbazole with 1.2 mL dimethylsulfoxide and add 28.8 mL 0.05 M Tris-HCl, pH 7.3, and 20 μL 3% H 2 O 2 (w/v). Prepare solution freshly each day.
Diaminobenzidine:
Dissolve 25 mg 3,3′-diaminobenzidine with 50 mL 0.05 M Tris-HCl, pH 7.3, and add 40 μL 3% H2O2 (w/v). Prepare solution freshly each day.
Optimal working dilutions must be determined by end user.
Immunohistochemistry Protocol for Anti-Neurofilament 200 kD
Ideal specimens are obtained from frozen sections from shock-frozen tissue samples. The frozen sections are dried in the air and then fixed with acetone at -15 to -25°C for 10 min. Excess acetone is allowed to evaporate at 15-25°C. Material fixed in alcohol and embedded in paraffin can also be used, see (Altmannsberger et al., 1982). The antibody appears to react with tissue fixed in formaldehyde for a short time (10 min) (Debus et al., 1983). Other fixation conditions must be first tested by the investigator.
It is advantageous to block unspecific binding sites by overlaying the sections with fetal calf serum for 20-30 min at 15-25°C. Excess of fetal calf serum is removed by decanting before application of the antibody solution. Cytocentrifuge preparations of single cells or cell smears are also fixed in acetone. These preparations should, however, not be dried in the air. Instead, the excess acetone is removed by briefly washing in phosphate-buffered saline (PBS).
Further treatment is then as follows:
Overlay the preparation with 10-20 μL antibody solution and incubate in a humid chamber at 37°C for 1 h.
Dip the slide briefly in PBS and then wash 3 times in PBS for 3 min (use fresh PBS each time)
Wipe the margins of the preparation dry and overlay the preparation with 10-20 μL of an anti-mouse Ig-FITC or anti-mouse Ig-POD antibody and allow to incubate for 1 h at 37°C in a humid chamber.
Wash the slide as described above.
The preparation must not be allowed to dry out during any of the steps.
If using an indirect immunofluorescence technique, the preparation should be overlaid with a suitable embedding medium (e.g. Moviol, Hoechst) and examined under the fluorescence microscope. If a POD-conjugate has been used as the secondary antibody, the preparation should be overlaid with a substrate solution (see below) and incubated at 15-25°C until a clearly visible red-brown color develops. A negative control (e.g. only the secondary antibody) should remain unchanged in color during this incubation period. Subsequently, the substrate is washed off with PBS and the preparation is stained, if desired, with hemalum stain for about 1 min. The hemalum solution is washed off with PBS, the preparation is embedded and examined.
Substrate solutions:
Aminoethyl-carbazole:
Dissolve 2 mg 3-amino-9-ethylcarbazole with 1.2 mL dimethylsulfoxide and add 28.8 mL 0.05 M Tris-HCl, pH 7.3, and 20 μL 3% H 2 O 2 (w/v). Prepare solution freshly each day.
Diaminobenzidine:
Dissolve 25 mg 3,3′-diaminobenzidine with 50 mL 0.05 M Tris-HCl, pH 7.3, and add 40 μL 3% H2O2 (w/v). Prepare solution freshly each day.
Research Category
Neuroscience
Neuroscience
Research Sub Category
Neurofilament & Neuron Metabolism
Neuronal & Glial Markers
Neurofilament & Neuron Metabolism
Neuronal & Glial Markers
Physical form
Format: Purified
Purified immunoglobulin. Liquid. Buffer = 0.02M Phosphate buffer, 0.25M NaCl containing 0.1% sodium azide.
Storage and Stability
Maintain refrigerated at 2-8°C in undiluted aliquots for up to 6 months.DO NOT FREEZE
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class Code
10 - Combustible liquids
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Listings
Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.
JAN Code
MAB5256:
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Zhen Liu et al.
Molecular pain, 12 (2016-05-06)
Gαi-interacting protein (GINIP) is expressed specifically in dorsal root ganglion (DRG) neurons and functions in modulation of peripheral gamma-aminobutyric acid B receptor (GBR). Genetic deletion of GINIP leads to impaired responsiveness to GBR agonist-mediated analgesia in rodent. It is, however
Takashi D Y Kozai et al.
Biomaterials, 35(36), 9620-9634 (2014-09-02)
Chronic implantation of microelectrodes into the cortex has been shown to lead to inflammatory gliosis and neuronal loss in the microenvironment immediately surrounding the probe, a hypothesized cause of neural recording failure. Caspase-1 (aka Interleukin 1β converting enzyme) is known
Asiyeh Golabchi et al.
Biosensors & bioelectronics, 155, 112096-112096 (2020-02-25)
Intracortical microelectrodes are being developed to both record and stimulate neurons to understand brain circuitry or restore lost functions. However, the success of these probes is hampered partly due to the inflammatory host tissue responses to implants. To minimize the
Asiyeh Golabchi et al.
Biomaterials, 225, 119519-119519 (2019-10-11)
The inflammatory brain tissue response to implanted neural electrode devices has hindered the longevity of these implants. Zwitterionic polymers have a potent anti-fouling effect that decreases the foreign body response to subcutaneous implants. In this study, we developed a nanoscale
Amandine Robac et al.
Biomedicines, 9(12) (2021-12-25)
Spinal cord injury (SCI) is an incurable condition in which the brain is disconnected partially or completely from the periphery. Mainly, SCIs are traumatic and are due to traffic, domestic or sport accidents. To date, SCIs are incurable and, most
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service